Tag: biotechnology

Pfizer, BioNTech nab fast track tag, prep for major phase 3 COVID-19 vax test this month

BiotechnologyJuly 13, 2020

Pfizer and German mRNA partner BioNTech have grabbed an FDA fast track label as they look to start a late-stage, 30,000-patient COVID-19 vaccine...

Forbion Raises €185M to Fuel Late-Stage European Biotechs

BiotechnologyJuly 13, 2020

The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing of a fund aimed at investing in late-stage...

Angelini lands EU rights to Ovid’s phase 3 rare disease drug

BiotechnologyJuly 13, 2020

Ovid Therapeutics has offloaded the European rights to OV101 in a genetic nervous system disorder to Angelini Pharma. Italy’s Angelini Pharma is paying...

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

BiotechnologyJuly 13, 2020

While there are now more cell therapies on offer than ever before, there are obstacles still preventing them from becoming widely used.Cell therapy...

Russia Becomes The First Nation to Finish Human Trials For COVID-19 Vaccine

BiotechnologyJuly 13, 2020

--Sharing is Caring-- First COVID-19 Vaccine by RussiaHuman Trials Of Russia’s COVID-19 Vaccine Completed SuccessfullyAfter Russia’s COVID-19 vaccine candidate showed results that prove...

FDA spotlights eye safety in GSK anti-BCMA AdComm, but analysts expect approval anyway

BiotechnologyJuly 12, 2020

The multiple myeloma field is teeming with BCMA-targeting agents, including bispecific antibodies and CAR-T therapies. GlaxoSmithKline’s antibody-drug conjugate (ADC) could beat the others...

Tracey Mullen Promoted to CEO at Abveris; Garren Hilow Assumes Chief Business Officer Role

BiotechnologyJuly 12, 2020

July 13, 2020 -- Abveris, a leader in contract research antibody discovery, today announced the promotion of Tracey Mullen from Chief Operating...

Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded

BiotechnologyJuly 12, 2020

TOKYO, July 13, 2020 - (JCN Newswire) - Eisai Company, Ltd. announced today that it has entered into an industry-academia-government joint research agreement...